{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:00:12Z","timestamp":1789923612853,"version":"4.0.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Erectile dysfunction (ED) is highly associated to cardiovascular disease, especially arterial hypertension. Phosphodiesterase type 5 (PDE5) inhibitors and angiotensin II receptor blockers (ARB) are both common and efficient therapy in patients with ED and arterial hypertension, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To evaluate the effect of PDE5 inhibitor, sildenafil (S), and of ARB Losartan (L) in a continuous combined therapy for a long term on penile structures in a hypertensive rat model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>During 6 months, four groups of male spontaneously hypertensive rats (SHR) and one of Wistar-Kyoto (WKY) rats, as control group, were studied: no-treatment SHR, SHR with L, SHR with S, SHR with S+L, and no-treatment WKY. Cavernous smooth muscle (CSM) and vascular smooth muscle (VSM) from cavernous arteries, collagen type III (COL-III), and endothelial nitric oxide synthase (eNOS) expression in cavernous space were evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Functional and morphological differences between S and L in a continuous combined therapy vs. either drug as monotherapy on penile structures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After 6 months, SHR that received L, S, or combined therapy showed a similar reduction in blood pressure compared with untreated SHR. Nevertheless, SHR+L+S and control WKY showed significantly lower values of (i) CSM (P \u2009&amp;lt;\u20090.01), (ii) VSM (P \u2009&amp;lt;\u20090.01), and (iii) COL-III (P \u2009&amp;lt;\u20090.01) when compared with the untreated SHR and also with the SHR with monotherapy. Additionally, SHR+L+S, presented a higher eNOS expression in sinusoidal endothelium in comparison with the untreated SHR and the SHR with monotherapy (P \u2009&amp;lt;\u20090.01). In vitro studies revealed that SHR+L+S displayed a better relaxation response to acetylcholine than the untreated SHR and the SHR with monotherapy (P \u2009&amp;lt;\u20090.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results suggest that a long-term combined therapy using L and S is a useful tool for functional and structural modification in cavernous tissue from SHR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2007.00567.x","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T03:26:18Z","timestamp":1185420378000},"page":"1291-1303","source":"Crossref","is-referenced-by-count":33,"title":["Functional and Morphological Improvement in Erectile Tissue of Hypertensive Rats by Long-Term Combined Therapy with Phosphodiesterase Type 5 Inhibitor and Losartan"],"prefix":"10.1093","volume":"4","author":[{"given":"Jorge Eduardo","family":"Toblli","sequence":"first","affiliation":[{"name":"Laboratory of Experimental Medicine, Hospital Alem\u00e1n , Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Cao","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine, Hospital Alem\u00e1n , Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Lombra\u00f1a","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine, Hospital Alem\u00e1n , Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rivero","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine, Hospital Alem\u00e1n , Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,9,1]]},"reference":[{"key":"2024032600531496500_bb0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1524-6175.2002.00862.x","article-title":"Sexual dysfunction in patients with hypertension: Implications for therapy","volume":"4","author":"Ferrario","year":"2002","journal-title":"J Clin Hypertens"},{"key":"2024032600531496500_bb0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","article-title":"Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study","volume":"163","author":"Johannes","year":"2000","journal-title":"J Urol"},{"key":"2024032600531496500_bb0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0022-5347(05)67138-8","article-title":"Hypertension is associated with severe erectile dysfunction","volume":"164","author":"Burchardt","year":"2000","journal-title":"J Urol"},{"key":"2024032600531496500_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ijir.3900725","article-title":"Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension","volume":"13","author":"Burchardt","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032600531496500_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2165\/00002018-199308060-00003","article-title":"Drug induced male sexual dysfunction","volume":"8","author":"Lue","year":"1993","journal-title":"Drug Safety"},{"key":"2024032600531496500_bb0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0895-7061(99)00268-X","article-title":"Morphologic changes in cavernous tissue in spontaneously hypertensive rats","volume":"13","author":"Toblli","year":"2000","journal-title":"Am J Hypertens"},{"key":"2024032600531496500_bb0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1159\/000082598","article-title":"Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats","volume":"24","author":"Toblli","year":"2004","journal-title":"Am J Nephrol"},{"key":"2024032600531496500_bb0045","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1743-6109.2006.00235.x","article-title":"Differences between Candesartan and Hydralazine in the protection of penile structures in spontaneously hypertensive rats","volume":"3","author":"Mazza","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600531496500_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00228-002-0456-3","article-title":"Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men","volume":"58","author":"Fogari","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"2024032600531496500_bb0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00000441-200105000-00006","article-title":"Sexual dysfunction in hypertensive patients treated with losartan","volume":"321","author":"Llisterri","year":"2001","journal-title":"Am J Med Sci"},{"issue":"3","key":"2024032600531496500_bb0060","first-page":"7","article-title":"Current treatments and emerging therapeutic approaches in male erectile dysfunction","volume":"88","author":"Hatzichristou","year":"2001","journal-title":"BJU Int"},{"key":"2024032600531496500_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1743-6109.2005.00197.x","article-title":"Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells","volume":"3","author":"Vernet","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600531496500_bb0070","doi-asserted-by":"crossref","first-page":"9M","DOI":"10.1016\/S0002-9149(03)00824-5","article-title":"Overview of phosphodiesterase 5 inhibition in erectile dysfunction","volume":"92","author":"Rosen","year":"2003","journal-title":"Am J Cardiol"},{"key":"2024032600531496500_bb0075","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2165\/00003495-200464140-00003","article-title":"Treatment of erectile dysfunction in patients with cardiovascular disease: Guide to drug selection","volume":"64","author":"Jackson","year":"2004","journal-title":"Drugs"},{"key":"2024032600531496500_bb0080","doi-asserted-by":"crossref","first-page":"21C","DOI":"10.1016\/S0002-9149(99)00044-2","article-title":"Sildenafil citrate and blood-pressure-lowering drugs: Results of drug interaction studies with an organic nitrate and a calcium antagonist","volume":"83","author":"Webb","year":"1999","journal-title":"Am J Cardiol"},{"key":"2024032600531496500_bb0085","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/00004872-200018120-00022","article-title":"Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil study group","volume":"18","author":"Zusman","year":"2000","journal-title":"J Hypertens"},{"key":"2024032600531496500_bb0090","doi-asserted-by":"crossref","first-page":"47M","DOI":"10.1016\/S0002-9149(03)00075-4","article-title":"Cardiovascular effects of tadalafil in patients on common antihypertensive therapies","volume":"92","author":"Kloner","year":"2003","journal-title":"Am J Cardiol"},{"key":"2024032600531496500_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0895-7061(00)01177-8","article-title":"Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil study group","volume":"14","author":"Kloner","year":"2001","journal-title":"Am J Hypertens"},{"key":"2024032600531496500_bb0100","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1743-6109.2005.00150.x","article-title":"Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives","volume":"2","author":"Van Ahlen","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600531496500_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.ijir.3900275","article-title":"Vascular control mechanisms in penile erection: Phylogeny and the inevitability of multiple and overlapping systems","volume":"9","author":"Adams","year":"1997","journal-title":"Int J Impot Res"},{"key":"2024032600531496500_bb0110","doi-asserted-by":"crossref","first-page":"R682","DOI":"10.1152\/ajpregu.00349.2002","article-title":"Erectile dysfunction in spontaneously hypertensive rats: Pathophysiological mechanisms","volume":"284","author":"Berhr-Roussel","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024032600531496500_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1743-6109.2006.00397.x","article-title":"Study of interstitial cells in the penis: Human study","volume":"4","author":"Shafik","year":"2007","journal-title":"J Sex Med"},{"key":"2024032600531496500_bb0120","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0022-5347(01)66200-1","article-title":"Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit","volume":"155","author":"Azadzoi","year":"1996","journal-title":"J Urol"},{"key":"2024032600531496500_bb0125","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-5347(01)65133-4","article-title":"Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model","volume":"157","author":"Azadzoi","year":"1997","journal-title":"J Urol"},{"key":"2024032600531496500_bb0130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1743-6109.2006.00282.x","article-title":"Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice","volume":"3","author":"Behr-Roussel","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600531496500_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1743-6109.2005.00098_1.x","article-title":"Testing endothelial function of brachial and cavernous arteries in patients with erectile dysfunction","volume":"3","author":"Mazo","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600531496500_bb0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1152\/physrev.1995.75.1.191","article-title":"Physiology of penile erection","volume":"75","author":"Andersson","year":"1995","journal-title":"Physiol Rev"},{"key":"2024032600531496500_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1291\/hypres.27.253","article-title":"Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide","volume":"27","author":"Ushiyama","year":"2004","journal-title":"Hypertens Res"},{"key":"2024032600531496500_bb0150","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bbrc.2003.11.034","article-title":"Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF","volume":"312","author":"Angulo","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032600531496500_bb0155","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.HYP.0000068202.42431.CC","article-title":"PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers","volume":"41","author":"Kimura","year":"2003","journal-title":"Hypertension"},{"key":"2024032600531496500_bb0160","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000075362.08363.a4","article-title":"Erectile physiological and pathophysiological pathways involved in erectile dysfunction","volume":"170","author":"Andersson","year":"2003","journal-title":"J Urol"},{"key":"2024032600531496500_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1291\/hypres.27.263","article-title":"RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats","volume":"27","author":"Moriki","year":"2004","journal-title":"Hypertens Res"},{"key":"2024032600531496500_bb0170","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/sj.bjp.0706408","article-title":"Inhibition of RhoA\/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension","volume":"146","author":"Guilluy","year":"2005","journal-title":"Br J Pharmacol"},{"key":"2024032600531496500_bb0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","article-title":"L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures","volume":"9","author":"Valente","year":"2003","journal-title":"Nitric Oxide"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515316428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515316428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/4\/5\/1291\/47812965\/jsm_4_5_1291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/4\/5\/1291\/47812965\/jsm_4_5_1291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:42:52Z","timestamp":1711417372000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/4\/5\/1291\/6890499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,9,1]]},"published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2007.00567.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,9]]},"published":{"date-parts":[[2007,9,1]]}}}